(diroximel fumarate) reinforce the treatment’s positive gastrointestinal tolerability profile
Biogen advances leading research to help inform future patient management including new information on the clinical profile of extended interval dosing with natalizumab
CAMBRIDGE, Mass., April 16, 2021 (GLOBE NEWSWIRE) Biogen Inc. (Nasdaq: BIIB) today announced new data from its industry-leading portfolio of multiple sclerosis (MS) therapies to be presented at the American Academy of Neurology (AAN) 2021 Virtual Annual Meeting, April 17-22. The presentations include data on quality of life benefits and analyses of extended interval dosing (EID) with TYSABRI
® (natalizumab) as well as new real-world experience data from VUMERITY
® (diroximel fumarate). The research adds to the vast clinical knowledge Biogen continues to advance as part of its commitment to the care of people living with MS.
Biogen Inc.: New Data at AAN 2021 from Across Biogen s MS Portfolio Demonstrate Positive Impact of Treatment on People Living with Relapsing Multiple Sclerosis (natalizumab) can lead to meaningful improvements in mental and social health compared to Ocrevus (ocrelizumab) (diroximel fumarate) reinforce the treatment s positive gastrointestinal tolerability profile
Biogen advances leading research to help inform future patient management including new information on the clinical profile of extended interval dosing with natalizumab
CAMBRIDGE, Mass., April 16, 2021(Nasdaq: BIIB) today announced new data from its industry-leading portfolio of multiple sclerosis (MS) therapies to be presented at the American Academy of Neurology (AAN) 2021 Virtual Annual Meeting, April 17-22. The presentations include data on quality of life benefits and analyses of extended interval dosing (EID) with TYSABRI
New Data at AAN 2021 from Across Biogen s MS Portfolio Demonstrate Positive Impact of Treatment on People Living with Relapsing Multiple Sclerosis forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
i know that i ve taken a facebook sabbatical over the past six months or so. it felt like it was a time suck. i wasn t getting much out of it. you know what? i don t miss it. why do you think it is that taking a break from social media is a good thing for our well-being? sometimes what deer on facebook and other social media is actually comparing ourselves to others. and avoiding our real life. and so sometimes it s good to take that break, reconnect in real life with your family and friends. understand that you do have a good life, you re unique, you re special and you have things that are important to you in the real world setting. but sometimes after doing that break, it s actually good to get back on facebook and connect with family and friends again and know you have other people out there that care about you. it s the phenomenon when you go on social media, it feels like you have to keep up with the joness, everybody is smiling, everybody is posting things that are happy an